Financial burden of health care for Buruli ulcer patients in Nigeria: the patients’ perspective-Reference-Cited by-同舟云学术

Financial burden of health care for Buruli ulcer patients in Nigeria: the patients’ perspective

Published:2016-12-15 Issue:1 Volume:9 Page:36-43
ISSN:1876-3413
Container-title:International Health
language:en
Short-container-title:Int. Health

Author:

Chukwu Joseph N.,Meka Anthony O.,Nwafor Charles C.,Oshi Daniel C.,Madichie Nelson O.,Ekeke Ngozi,Anyim Moses C.,Chukwuka Alphonsus,Obinna Mbah,Adegbesan Julie,Njoku Martin,Soyinka Festus O.,Adelokiki Adebola O.,Enemuoh Isreal O.,Okolie Patrick I.,Edochie Joseph E.,Offor Jonah B.,Ushaka Joseph,Ukwaja Kingsley N.

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health,General Medicine,Health (social science)

Link

http://academic.oup.com/inthealth/article-pdf/9/1/36/9572649/ihw056.pdf

Reference21 articles.

1. Epidemiology and management of Buruli ulcer

2. Buruli ulcer (Mycobacterium ulcerans infection)

3. Risk factors for Mycobacterium ulcerans infection

4. Neglected tropical diseases in Sub-Saharan Africa: review of their prevalence, distribution, and disease burden;Hotez;PLoSNegl Trop Dis,2009

5. WHO . Buruli ulcer. Geneva: World Health Organization; 2015. http://apps.who.int/neglected_diseases/ntddata/buruli/buruli.html [accessed 17 November 2016].

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of economic factors in shaping and constituting the household burden of neglected tropical diseases of the skin: Qualitative findings from Ghana and Ethiopia;Social Science & Medicine;2024-09

2. Financial hardship among patients suffering from neglected tropical diseases: A systematic review and meta-analysis of global literature;PLOS Neglected Tropical Diseases;2024-05-13

3. Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana;NIHR Open Research;2023-02-24

4. Buruli-RifDACC: Evaluation of the efficacy and cost-effectiveness of high-dose versus standard-dose rifampicin on outcomes in Mycobacterium ulcerans disease, a protocol for a randomised controlled trial in Ghana;NIHR Open Research;2022-11-29

5. Factors associated with catastrophic health expenditure in sub-Saharan Africa: A systematic review;PLOS ONE;2022-10-20